Compare Novartis AG (NVS) vs SpaceX (SPCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs SpaceX — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while SpaceX trades at $135.65 (market cap $1.76T). The key difference: SpaceX is far larger — about 6× Novartis AG's market cap, and Novartis AG pays a 3.07% dividend while SpaceX pays none. Which is the better fit depends on your goals.
| NVS | SPCX | |
|---|---|---|
Market Cap | $295.37B | $1.76T |
Sector | Health | Technology |
52-Week High | $168.62 | $202.09 |
52-Week Low | $119.31 | $108.27 |
Enterprise Value | $336.69B | $1.70T |
Dividend Yield | 3.07% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →
